艳妇乳肉豪妇荡乳AV无码福利,最新久久国产亚洲高清观看,91久久无码99精品高潮久,中文乱码字字幕在线第5页一,免费大片av手机看片不卡高清,91精品国产91久久久久久青草_精品国产亚洲人成在线观看_91国在线啪精品一区_国产一区二区三区在线免费_国产精品v欧美精品∨日韩_日韩欧美国产三级_国产三级精品三级在专区_国产精选第一页_欧美国产精品va在线观看 ,中文字幕一区二区三区精华液_亚洲欧美一区二区视频_麻花豆剧国产MV在视频_红桃AV一区二区三区在线无码AV ,国产欧美日本亚洲精品一5|99视频在线精品国自产拍亚瑟|国产色精品vr一区区三区|国产精品极品美女自在线观看免费|欧洲精品精美色视频在线观看

最近搜索:細(xì)胞培養(yǎng) 微生物學(xué) 分子生物 生物化學(xué)
首頁(yè)>>免疫學(xué)>>一抗>>錯(cuò)配修復(fù)蛋白6抗體
錯(cuò)配修復(fù)蛋白6抗體
  • 產(chǎn)品貨號(hào):
    BN40967R
  • 中文名稱:
    錯(cuò)配修復(fù)蛋白6抗體
  • 英文名稱:
    Rabbit anti-MSH6 Polyclonal antibody
  • 品牌:
    Biorigin
  • 貨號(hào)

    產(chǎn)品規(guī)格

    售價(jià)

    備注

  • BN40967R-100ul

    100ul

    ¥2360.00

    交叉反應(yīng):Human,Rat(predicted:Mouse,Dog,Pig,Cow,Rabbit,Sheep) 推薦應(yīng)用:WB,IHC-P,IHC-F,IF,ELISA

  • BN40967R-200ul

    200ul

    ¥3490.00

    交叉反應(yīng):Human,Rat(predicted:Mouse,Dog,Pig,Cow,Rabbit,Sheep) 推薦應(yīng)用:WB,IHC-P,IHC-F,IF,ELISA

產(chǎn)品描述

英文名稱MSH6
中文名稱錯(cuò)配修復(fù)蛋白6抗體
別    名DNA mismatch repair protein MSH6; G/T mismatch binding protein; GTBP; GTMBP; HNPCC 5; HNPCC5; HSAP; MSH 6; mutS (E. coli) homolog 6; MutS alpha 160 kDa subunit; mutS homolog 6; p160; Sperm associated protein; MSH6_HUMAN; MutS Protein Homolog 6.  
研究領(lǐng)域腫瘤  免疫學(xué)  轉(zhuǎn)錄調(diào)節(jié)因子  
抗體來(lái)源Rabbit
克隆類型Polyclonal
交叉反應(yīng)Human, Rat,  (predicted: Mouse, Dog, Pig, Cow, Rabbit, Sheep, )
產(chǎn)品應(yīng)用WB=1:500-2000 ELISA=1:5000-10000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 (石蠟切片需做抗原修復(fù))
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.
分 子 量153kDa
細(xì)胞定位細(xì)胞核 
性    狀Liquid
濃    度1mg/ml
免 疫 原KLH conjugated synthetic peptide derived from human MSH6:812-910/1360 
亞    型IgG
純化方法affinity purified by Protein A
儲(chǔ) 存 液0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
保存條件Shipped at 4℃. Store at -20 °C for one year. Avoid repeated freeze/thaw cycles.
PubMedPubMed
產(chǎn)品介紹Defects in MSH6 are a cause of hereditary non-polyposis colorectal cancer (HNPCC) (Lynch syndrome). HNPCC is an autosomal, dominantly inherited disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early onset colorectal carcinoma (crc) and extra-colonic cancers of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the western world. MSH6 is central to mismatch DNA repair.

Function:
Component of the post-replicative DNA mismatch repair system (MMR). Heterodimerizes with MSH2 to form MutS alpha, which binds to DNA mismatches thereby initiating DNA repair. When bound, MutS alpha bends the DNA helix and shields approximately 20 base pairs, and recognizes single base mismatches and dinucleotide insertion-deletion loops (IDL) in the DNA. After mismatch binding, forms a ternary complex with the MutL alpha heterodimer, which is thought to be responsible for directing the downstream MMR events, including strand discrimination, excision, and resynthesis. ATP binding and hydrolysis play a pivotal role in mismatch repair functions. The ATPase activity associated with MutS alpha regulates binding similar to a molecular switch: mismatched DNA provokes ADP-->ATP exchange, resulting in a discernible conformational transition that converts MutS alpha into a sliding clamp capable of hydrolysis-independent diffusion along the DNA backbone. This transition is crucial for mismatch repair. MutS alpha may also play a role in DNA homologous recombination repair.

Subunit:
Heterodimer consisting of MSH2-MSH6 (MutS alpha). Forms a ternary complex with MutL alpha (MLH1-PMS1). Interacts with EXO1. Part of the BRCA1-associated genome surveillance complex (BASC), which contains BRCA1, MSH2, MSH6, MLH1, ATM, BLM, PMS2 and the RAD50-MRE11-NBS1 protein complex. This association could be a dynamic process changing throughout the cell cycle and within subnuclear domains. Interacts with ATR.

Subcellular Location:
Nucleus.

Post-translational modifications:
The N-terminus is blocked.
Phosphorylated upon DNA damage, probably by ATM or ATR.
Phosphorylated by PRKCZ, which may prevent MutS alpha degradation by the ubiquitin-proteasome pathway.

DISEASE:
Defects in MSH6 are the cause of hereditary non-polyposis colorectal cancer type 5 (HNPCC5) [MIM:600678]. Mutations in more than one gene locus can be involved alone or in combination in the production of the HNPCC phenotype (also called Lynch syndrome). Most families with clinically recognized HNPCC have mutations in either MLH1 or MSH2 genes. HNPCC is an autosomal, dominantly inherited disease associated with marked increase in cancer susceptibility. It is characterized by a familial predisposition to early onset colorectal carcinoma (CRC) and extra-colonic cancers of the gastrointestinal, urological and female reproductive tracts. HNPCC is reported to be the most common form of inherited colorectal cancer in the Western world. Cancers in HNPCC originate within benign neoplastic polyps termed adenomas. Clinically, HNPCC is often divided into two subgroups. Type I: hereditary predisposition to colorectal cancer, a young age of onset, and carcinoma observed in the proximal colon. Type II: patients have an increased risk for cancers in certain tissues such as the uterus, ovary, breast, stomach, small intestine, skin, and larynx in addition to the colon. Diagnosis of classical HNPCC is based on the Amsterdam criteria: 3 or more relatives affected by colorectal cancer, one a first degree relative of the other two; 2 or more generation affected; 1 or more colorectal cancers presenting before 50 years of age; exclusion of hereditary polyposis syndromes. MSH6 mutations appear to be associated with atypical HNPCC and in particular with development of endometrial carcinoma or atypical endometrial hyperplasia, the presumed precursor of endometrial cancer. Defects in MSH6 are also found in familial colorectal cancers (suspected or incomplete HNPCC) that do not fulfill the Amsterdam criteria for HNPCC.

Similarity:
Belongs to the DNA mismatch repair MutS family.
Contains 1 PWWP domain.

SWISS:
P52701

Gene ID:
2956

Database links:

Entrez Gene: 2956 Human

Entrez Gene: 17688 Mouse

Entrez Gene: 100360342 Rat

Omim: 600678 Human

SwissProt: P52701 Human

SwissProt: P54276 Mouse

Unigene: 445052 Human

Unigene: 18210 Mouse



Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.

MSH6是DNA錯(cuò)配修復(fù)系統(tǒng)的基因組成之一。DNA錯(cuò)配修復(fù)系統(tǒng)由hMLH1,hMSH2,hPMS1,hPMS2,hMSH6和hMSH3等基因組成,這套系統(tǒng)的存在,可保證遺傳物質(zhì)的完整性和穩(wěn)定性,避免遺傳物質(zhì)的突變產(chǎn)生,保證DNA復(fù)制的高保真度。

































image.png

image.png

image.png

image.png

林西县| 德阳市| 随州市| 望奎县| 图片| 徐汇区| 中江县| 河津市| 仁化县| 偏关县| 遵义市| 泸水县| 平山县| 哈巴河县| 彩票| 鄯善县| 雅江县| 平乡县| 双辽市| 凌海市| 西乌| 阿克陶县| 嘉峪关市| 北碚区| 合作市| 同江市| 吴堡县| 尚志市| 腾冲县| 通榆县| 仁化县| 奇台县| 任丘市| 汝南县| 平塘县| 武邑县| 天门市| 江陵县| 商城县| 资兴市| 雷波县|